CG: Surpassing Price Targets
Carlyle Group Inc (Symbol: CG) has recently soared above the average analyst target of $46.87, with shares trading at $46.91 each. When a stock hits the mark set by an analyst, it prompts a fork in the road for the expert: either reevaluate and elevate the target price or downgrade based on valuation concerns. The course of action taken often hinges on the underlying business catalysts propelling the stock upwards, signaling the need for a potential target adjustment.
Analysts’ Divergent Views
Within the Zacks coverage sphere, 15 analysts contribute to Carlyle Group Inc’s average target price. This numerical beacon is a mere statistical calculation; beneath the surface lie analysts with differing targets. Some foresee a target as low as $32.00, while others aim high at $64.00, leading to a notable standard deviation of $10.041.
The Collective Wisdom of Averages
The essence of examining the average target price for CG lies in tapping into a “wisdom of crowds” approach. This method amalgamates the insights of all contributing analysts into a singular figure, diverging from the outlook of a solitary expert. As CG transcends the $46.87 target, investors are prompted to delve deeper, contemplating whether this milestone is a mere waypoint to loftier peaks, or if the valuation has stretched thin, warranting a strategic review. Below is a breakdown of the analysts’ current sentiments towards Carlyle Group Inc:
CG Analyst Ratings Review | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong buy ratings: | 7 | 7 | 7 | 8 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 8 | 8 | 8 | 6 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.19 | 2.19 | 2.19 | 2.0 |
The average rating ranges from 1 to 5, where 1 represents a Strong Buy and 5 indicates a Strong Sell. The data in this article is sourced from Zacks Investment Research via Quandl.com. Access the latest Zacks research report on CG — FREE.
Explore 10 ETFs With Significant Upside to Analyst Targets »
Further Insights:
Discover Institutional Investors of NBEV
Explore Institutional Investors of ARG
Delve into ALCS Historical Stock Prices
The author’s viewpoints expressed herein are personal and not reflective of Nasdaq, Inc.’s opinions.